6-(2,5-dimethylfuran-3-yl)-2-phenyl-1H-pyrazolo[3,4-b]pyridin-3(2H)-one

ID: ALA4238380

PubChem CID: 39047495

Max Phase: Preclinical

Molecular Formula: C18H15N3O2

Molecular Weight: 305.34

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cc(-c2ccc3c(=O)n(-c4ccccc4)[nH]c3n2)c(C)o1

Standard InChI:  InChI=1S/C18H15N3O2/c1-11-10-15(12(2)23-11)16-9-8-14-17(19-16)20-21(18(14)22)13-6-4-3-5-7-13/h3-10H,1-2H3,(H,19,20)

Standard InChI Key:  BHJCGOXOUGUHEX-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 23 26  0  0  0  0  0  0  0  0999 V2000
    5.1948  -19.5218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1936  -20.3413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9017  -20.7503    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8999  -19.1129    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.6085  -19.5182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6133  -20.3413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3977  -20.5911    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8777  -19.9223    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.3899  -19.2593    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.6547  -21.3668    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.6949  -19.9175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4870  -19.1133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4008  -18.2969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6014  -18.1272    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1930  -18.8350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7400  -19.4421    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1050  -20.6214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9214  -20.6169    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3267  -19.9062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9095  -19.1986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0944  -19.2066    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0079  -17.7499    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3803  -18.9207    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  5  1  0
  7 10  2  0
  8 11  1  0
  1 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 12  1  0
 11 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 11  1  0
 13 22  1  0
 15 23  1  0
M  END

Associated Targets(Human)

LOX Tchem Lysyl oxidase (75 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LOXL2 Tchem Lysyl oxidase homolog 2 (834 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LOXL3 Tchem Lysyl oxidase homolog 3 (44 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LOXL4 Tchem Lysyl oxidase homolog 4 (29 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 305.34Molecular Weight (Monoisotopic): 305.1164AlogP: 3.59#Rotatable Bonds: 2
Polar Surface Area: 63.82Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 8.28CX Basic pKa: 2.26CX LogP: 4.43CX LogD: 4.38
Aromatic Rings: 4Heavy Atoms: 23QED Weighted: 0.62Np Likeness Score: -1.03

References

1. Hajdú I, Kardos J, Major B, Fabó G, Lőrincz Z, Cseh S, Dormán G..  (2018)  Inhibition of the LOX enzyme family members with old and new ligands. Selectivity analysis revisited.,  28  (18): [PMID:30098867] [10.1016/j.bmcl.2018.07.001]
2. Dechering K; Duffey M.  (2022)  Replenishing the malaria drug discovery pipeline: Screening and hit evaluation of the MMV Hit Generation Library 1 (HGL1) against asexual blood stage Plasmodium falciparum ,using a nano luciferase reporter read-out,  [10.6019/CHEMBL4888484]